The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients

Medicine

Volumn 78, Issue 4, 1999, Pages 270-283

  Felker, G Michael ^a   Hu, Weimin ^a   Hare, Joshua M ^a   Hruban, Ralph H ^a   Baughman, Kenneth L ^a   Kasper, Edward K ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; HEART DILATATION; HEART MUSCLE BIOPSY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMYLOIDOSIS; ANTINEOPLASTIC AGENTS; CARDIOMYOPATHY, DILATED; DIAGNOSIS, DIFFERENTIAL; DOXORUBICIN; FEMALE; HEART DISEASES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYOCARDITIS; MYOCARDIUM; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; SARCOIDOSIS;

EID: 0032854585     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005792-199907000-00005     Document Type: Article

References (67)

1. Anonymous. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br Heart J 44: 672-73, 1980.
2. Aretz HT. Myocarditis: The Dallas Criteria. Hum Pathol 18: 619-24, 1987.
3. Baughman KL. History and current techniques of endomyocardial biopsy. In: Baumgartner WA, Reitz BA, Achuff SC, eds. Heart and heart-lung transplantation. Philadelphia: WB Saunders, p 165, 1990.
4. Bourassa MG, Gurne O, Bangdiwala SI, Ghali JK, Young JB, Rousseau M, Johnstone DE, Yusuf S. Natural history and patterns of current practice in heart failure. J Am Coll Cardiol 22: 14A-19A, 1993.
5. Brown CS, Bertolet BD. Peripartum cardiomyopathy: A comprehensive review. Am J Obstet Gynecol 178: 409-14, 1998.
6. Carvalho A, Brandao A, Martinez EE, Alexopoulos D, Lima VC, Andrade JL, Ambrose JA. Prognosis in peripartum cardiomyopathy. Am J Cardiol 64: 540-42, 1989.
7. Cassling RS, Linder J, Sears TD, Waller BF, Rogler WC, Wilson JE, Kugler JD, Kay DH, Dillon JC, Slack JD, McManus BM. Quantitative evaluation of inflammation in heart biopsy specimens in idiopathically failing or irritable hearts: Experience in 80 pediatric and adult hearts. Am Heart J 110: 713-20, 1985.
8. Cooper LT, Berry GJ, Shabetai R. Idiopathic giant-cell myocarditis -Natural history and treatment. N Engl J Med 336: 1860-66, 1997.
9. Davidoff R, Palacios I, Southern J, Fallon JT, Newell J, Dec GW. Giant cell versus lymphocytic myocarditis. Circulation 83: 953-61, 1991.
10. Dec GW, Fallon JT, Southern JF, Palacios I. "Borderline" myocarditis: An indication for repeat endomyocardial biopsy. J Am Coll Cardiol 15: 283-89, 1990.
11. Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med 331: 1564-75, 1994.
12. Dec GW, Palacios IF, Fallon JT, Aretz HT, Mills J, Lee D, Johnson RA. Active myocarditis in the spectrum of acute dilated cardiomyopathies: Clinical features, histologic correlates, and clinical outcome. N Engl J Med 312: 885-90, 1985.
13. Deckers JW, Hare JM, Baughman KL. Complications of transvenous right ventricular endomyocardial biopsy in adult patients with cardiomyopathy: A seven year survey of 546 consecutive diagnostic procedures in a tertiary referral center. J Am Coll Cardiol 19: 43-17, 1992.
14. Demakis JG, Rahimtoola SH, Sutton GC, Meadows WR, Szanto PB, Tobin JR, Gunnar RM. Natural course of peripartum cardiomyopathy. Circulation 44: 1053-61, 1971.
15. Falk RH, Plehn JF, Deering T, Schick EC, Boinay P, Rubinow A, Skinner M, Cohen AS. Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. Am J Cardiol 59: 418-22, 1987.
16. Fenoglio JJ, Ursell PC, Kellog CF, Drusm RE, Weiss MB. Diagnosis and classification of myocarditis by endomyocardial biopsy. N Engl J Med 308: 12-18, 1983.
17. Fields CL, Ossorio MA, Roy TM, Denny DM, Varga DW. Thallium-201 scintigraphy in the diagnosis and management of myocardial sarcoidosis. South Med J 83: 339-42, 1990.
18. Fleming HA. Sarcoid heart disease. Br Med J 292: 1095-96, 1986.
19. Fowler MB, Laser JA, Hopkins GL, Minobe W, Bristow MR. Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: Progressive receptor down-regulation and subsensitivity to agonist response. Circulation 74: 1290-1302, 1986.
20. Freter CE, Lee TC, Billingham ME, Chak L, Bristow MR. Doxorubicin cardiac toxicity manifesting seven years after treatment. Case report and review. Am J Med 80: 483-85, 1986.
21. Grogan M, Redfield MM, Bailey KR, Reeder GS, Gersh BJ, Edwards WD, Rodeheffer RJ. Long-term outcome of patients with biopsy-proved myocarditis: Comparison with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 26: 80-84, 1995.
22. Hare JM, Baughman KL. Myocarditis: Current understanding of the etiology, pathophysiology, natural history and management of inflammatory diseases of the myocardium. Cardiol Rev 2: 165-73, 1994.
23. Hare JM, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Baughman KL. Echocardiographic validation of fulminant myocarditis as a distinct clinical entity. J Heart Lung Transplant 16: 91, 1997.
24. Hare JM, Walford GD, Hruban RH, Hutchins GM, Deckers JW, Baughman KL. Ischemic cardiomyopathy: Endomyocardial biopsy and ventriculographic evaluation of patients with congestive heart failure, dilated cardiomyopathy, and coronary artery disease. J Am Coll Cardiol 20: 1318-25, 1992.
25. Herskowitz A, Ahmed-Ansari A, Neumann DA, Beschorner WE, Rose NR, Soule LM, Burek CL, Sell KW, Baughman KL. Induction of major histocompatibility complex antigens within the myocardium of patients with active myocarditis: A nonhistologic marker of myocarditis. J Am Coll Cardiol 15: 624-32, 1990.
26. Herskowitz A, Campbell S, Deckers JW, Kasper EK, Boehmer JP, Hadian D, Neumann DA, Baughman KL. Demographic features and prevalence of idiopathic myocarditis in patients undergoing endomyocardial biopsy. Am J Cardiol 71: 982-86, 1993.
27. Ho KL, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 88: 107-15, 1993.
28. Hosenpud JD, DeMarco T, Frazier OH, Griffith BP, Uretsky BF, Menkis AH, O'Connell JB, Olivari MT, Valentine HA. Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Circulation 84(Suppl 3): 338-43, 1991.
29. Hrobon P, Kuntz KM, Hare JM. Should endomyocardial biopsy be performed for detection of myocarditis? A decision analytic approach. J Heart Lung Transplant 17: 479-86, 1998.
30. Jones SR, Herskowitz A, Hutchins GM, Baughman KL. Effects of immunosuppressive therapy in biopsy-proved myocarditis and borderline myocarditis on left ventricular function. Am J Cardiol 68: 370-76, 1991.
31. Kasper EK, Agema W, Hutchins GM, Deckers JW, Hare JM, Baughman KL. The causes of dilated cardiomyopathy: A clinicopathologic review of 673 consecutive patients. J Am Coll Cardiol 23: 586-90, 1994.
32. Kyle RA, Gertz MA, Greipp PR, Witzig TE, Lust JA, Lacy MQ, Therneau TM. A trial of three regimens for primary amyloidosis: Colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med 336: 1202-7, 1997.
33. Lampert MB, Lange RM. Peripartum cardiomyopathy. Am Heart J 130: 860-70, 1995.
34. Lampert MB, Weinert L, Hibbard J, Korcarz C, Lindheimer M, Lange RM. Contractile reserve in patients with peripartum cardiomyopathy and recovered left ventricular function. Am J Obstet Gynecol 176: 189-95, 1997.
35. Lefrak EA, Pitha J, Rosenheim S, Gottlieb JA. A clinicopathologic analysis of Adriamycin toxicity. Cancer 32: 302-14, 1973.
36. Lieberman EB, Hutchins GM, Rose NR, Baughman KL. Clinicopathologic description of myocarditis. J Am Coll Cardiol 18: 1617-26, 1991.
37. Martino TA, Liu P, Sole MJ. Viral infection and the pathogenesis of dilated cardiomyopathy. Circ Res 74: 182-88, 1994.
38. Mason JW. Endomyocardial biopsy and the causes of dilated cardiomyopathy. J Am Coll Cardiol 23: 591-92, 1994.
39. Mason JW, Billingham ME, Ricci DR. Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy. Am J Cardiol 45: 1037-44, 1980.
40. Mason JW, O'Connell JB. Clinical merits of endomyocardial biopsy. Circulation 79: 971-79, 1989.
41. Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE. A clinical trail of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trail Investigators. N Engl J Med 333: 269-75, 1995.
42. McCarthy RE, Hruban RH, Kasper EK, Baughman KL. Association between the incidence of histopathologic myocarditis and non-polio enterovirus isolates in the United States. Circulation 98(Suppl 1). I-296, 1998.
43. McCarthy RE, Kasper EK. A review of the amyloidoses that infiltrate the heart. Clin Cardiol 21: 547-52, 1998.
44. Melvin KR, Richardson PJ, Olsen EG, Daly K, Jackson G. Peripartum cardiomyopathy due to myocarditis. N Engl J Med 307: 731-34, 1982.
45. Midei MG, DeMent SH, Feldman AM, Hutchins GM, Baughman KL. Peripartum myocarditis and cardiomyopathy. Circulation 81: 922-28, 1990.
46. Neumann DA, Burek CL, Baughman KL, Rose NR, Herskowitz A. Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy. J Am Coll Cardiol 16: 839-16, 1990.
47. O'Connell JB, Costanzo-Nordin MR, Subramanian R, Robinson JA, Wallis DE, Scanlon PJ, Gunnar RM. Peripartum cardiomyopathy: Clinical, hemodynamic, histologic and prognostic characteristics. J Am Coll Cardiol 8: 52-56, 1986.
48. Parrillo JE, Aretz HT, Palacios I, Fallon JT, Block PC. The results of transvenous endomyocardial biopsy can frequently be used to diagnose myocardial disease in patients with heart failure. Circulation 69: 93-101, 1984.
49. Pellikka PA, Holmes DR, Edwards WD, Nishimura RA, Tajik AJ, Kyle RA. Endomyocardial biopsy in 30 patients with primary amyloidosis and suspected cardiac involvement. Arch Intern Med 148: 662-66, 1988.
50. Pisani B, Taylor DO, Mason JW. Inflammatory myocardial diseases and cardiomyopathies. Am J Med 102: 459-69, 1997.
51. Richardson P, McKenna W, Bristow MR, Masich B, Mautner B, O'Connell JB, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93: 841-42, 1996.
52. Rizeq MN, Rickenbacher PR, Fowler MB, Billingham ME. Incidence of myocarditis in peripartum cardiomyopathy. Am J Cardiol 74: 474-77, 1994.
53. Roberts WC, McAllister HA, Ferrans VJ. Sarcoidosis of the heart. Am J Med 63: 86-107, 1977.
54. Rose NR, Wolfgram LJ, Herskowitz A, Beisel KW. Postinfectious autoimmunity: Two distinct phases of coxsackievirus B3-induced myocarditis. Ann N Y Acad Sci 475: 146-56, 1986.
55. Sakakibara S, Konno S. Endomyocardial biopsy. Jpn Heart J 3: 537-43, 1962.
56. See DM, Tilles JG. Viral myocarditis. Rev Infect Dis 13: 951-56, 1991.
57. Shammas RL, Movahed A. Sarcoidosis of the heart. Clin Cardiol 16: 462-72, 1993.
58. Sharma OP, Maheshwari A, Thaker K. Myocardial sarcoidosis. Chest 103: 253-58, 1993.
59. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 58: 1204-21, 1978.
60. Singal PK, Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med 339: 900-905, 1998.
61. Steinherz LJ, Steinherz PG, Tan CT, Heller G, Murphy ML. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA 266: 1672-77, 1991.
62. Sutton MS, Cole P, Plappert M, Saltzman D, Goldhaber SZ. Effects of subsequent pregnancy on left ventricular function in peripartum cardiomyopathy. Am Heart J 121: 1776-78, 1991.
63. Suzuki T, Kanda T, Kubota S, Imai S, Murata K. Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis. Chest 106: 1021-24, 1994.
64. Taki J, Nakajima K, Bunko H, Ohguchi M, Tonami N, Hisada K. Cardiac sarcoidosis demonstrated by Tl-201 and Ga-67 SPECT imaging. Clin Nucl Med 15: 636-37, 1990.
65. Waller BF, Slack JD, Orr CD, Adlam JH, Bournique VM. "Flaming," "smoldering," and "burned out": The fireside saga of myocarditis. J Am Coll Cardiol 18: 1627-30, 1991.
66. White M, Yanowitz F, Gilbert EM, Larrabee P, O'Connell JB, Anderson JL, Relund D, Mealey P, Abraham WT, Bristow MR. Role of beta-adrenergic receptor downregulation in the peak exercise response in patients with heart failure due to idiopathic dilated cardiomyopathy. Am J Cardiol 76: 1271-76, 1995.
67. Wynne J, Braunwald E. The cardiomyopathies and myocarditides. In: Braunwald E, ed. Heart disease: A textbook of cardiovascular medicine. 5th ed. Philadelphia: WB Saunders, p 1404, 1997.